RR874 Research Report Health and Safety Executive
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Interstitial Lung Diseases in Developing Countries
Rivera-Ortega P and Molina-Molina M. Interstitial Lung Diseases in Developing Countries. Annals of Global Health. 2019; 85(1): 4, 1–14. DOI: https://doi.org/10.5334/aogh.2414 REVIEW Interstitial Lung Diseases in Developing Countries Pilar Rivera-Ortega*,† and Maria Molina-Molina*,† More than 100 different conditions are grouped under the term interstitial lung disease (ILD). A diag- nosis of an ILD primarily relies on a combination of clinical, radiological, and pathological criteria, which should be evaluated by a multidisciplinary team of specialists. Multiple factors, such as environmental and occupational exposures, infections, drugs, radiation, and genetic predisposition have been implicated in the pathogenesis of these conditions. Asbestosis and other pneumoconiosis, hypersensitivity pneumonitis (HP), chronic beryllium disease, and smoking-related ILD are specifically linked to inhalational exposure of environmental agents. The recent Global Burden of Disease Study reported that ILD rank 40th in relation to global years of life lost in 2013, which represents an increase of 86% compared to 1990. Idiopathic pulmonary fibrosis (IPF) is the prototype of fibrotic ILD. A recent study from the United States reported that the incidence and prevalence of IPF are 14.6 per 100,000 person-years and 58.7 per 100,000 persons, respectively. These data suggests that, in large populated areas such as Brazil, Russia, India, and China (the BRIC region), there may be approximately 2 million people living with IPF. However, studies from South America found much lower rates (0.4–1.2 cases per 100,000 per year). Limited access to high- resolution computed tomography and spirometry or to multidisciplinary teams for accurate diagnosis and optimal treatment are common challenges to the management of ILD in developing countries. -
MS32-Chun-Red
Text19/12/2008 MATERIAL SAFETY DATA SHEET PRODUCT / MATERIAL: GLAZE MANUFACTURER / DISTRIBUTOR: LAGUNA CLAY COMPANY ADDRESS: 14400 Lomitas Avenue, City of Industry, CA 91746 PHONE / FAX / EMAIL: (626) 330-0631 / (626) 333-7694 / [email protected] SECTION I - PRODUCT INFORMATION TRADE NAME: MS32 SYNONYM: CHUN RED CHEMICAL FAMILY: Ceramic Blend SECTION II - HAZARDOUS INGREDIENTS Maximum OSHA PEL NIOSH REL ACGIH TLV INGREDIENT NAMEPercent CAS NUMBER TWA: (mg/m3) TWA: (mg/m3) TWA: (mg/m3) Barium or Barium Compounds5 7440-39-3 0.5 0.5 0.5 Calcium Carbonate7 1317-65-3 5 5 10 Lithium Carbonate1 554-13-2 Silica, Crystalline (Quartz)20 14808-60-7 10 mg/m3 / 0.05 0.05 %SiO2 + 2 Silicon Carbide1 409-21-2 15 10 Tin or Tin Compounds2 7440-31-5 2 2 Zinc or Zinc Compounds4 7440-66-6 5 5 5 SECTION III - PHYSICAL DATA BOILING POINT (°F) Not Applicable VAPOR PRESSURE Not Applicable VAPOR DENSITY Not Applicable SOLUBILITY IN WATER Insoluble SPECIFIC GRAVITY 1.7 – 3.7 PERCENT VOLATILE BY WEIGHT 0 EVAPORATION RATE 0 APPEARANCE AND ODOR Color varies between moist and dry state; no odor. SECTION IV - FIRE AND EXPLOSION HAZARD DATA FLASH POINT Not Flammable EXTINGUISHING MEDIA Water UNUSUAL FIRE OR EXPLOSION HAZARDS None SPECIAL FIRE FIGHTING PROCEDURES None SECTION V - REACTIVITY DATA STABILITY FACTOR Product is stable. INCOMPATIBILITY None HAZARDOUS DECOMPOSITION PRODUCTS None. Hazardous polymerization will not occur. CONDITIONS TO AVOID Inhalation of dust. Text10MS32 Text10Page 1 of 3 Text19/12/2008 MATERIAL SAFETY DATA SHEET SECTION VI - HEALTH HAZARD DATA Barium or Barium Compounds Chronic Toxicity: Chronic overexposure may lead to varying degress of paralysis of the extremities. -
Acute Bronchitis Treatment Without Antibiotics Owner: NCQA (AAB)
Measure Name: Acute Bronchitis Treatment without Antibiotics Owner: NCQA (AAB) Measure Code: BRN Lab Data: N Rule Description: The percentage of adults 18-64 years of age who had a diagnosis of acute bronchitis and were not dispensed an antibiotic prescription within three days of the encounter. General Criteria Summary 1. Continuous enrollment: One year prior to the date of the acute bronchitis index encounter through 7 days following that date (373 days) 2. Index Episode based: Yes 3. Anchor date: Episode date 4. Gaps in enrollment: One 45-day gap allowed in the period of continuous enrollment 5. Medical coverage: Yes 6. Drug coverage: Yes 7. Attribution time frame: Episode date 8. Exclusions apply: None 9. Age range: 18-64 10. Intake period: All but the last 7 days of the measurement year Summary of changes for 2013 1. No changes to this measure. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Denominator Description: All patients, aged 18 years as of the beginning of the year prior to the measurement year to 64 years as of the end of the measurement year, who had an outpatient or emergency department encounter with a diagnosis of acute bronchitis Inclusion Criteria: Patients as above with no comorbid condition during the twelve month period prior to the encounter, no prescription for an antibiotic medication filled 30 days prior to the encounter, and no competing diagnosis during the period from 30 days prior to the encounter to 7 days after the encounter. The intake period is from the beginning of the measurement year to 7 days prior to the end of the measurement year. -
Sore Throats: Causes and Cures
Vinod K. Anand, MD, FACS Nose and Sinus Clinic Sore Throats: Causes and Cures What Causes A Sore Throat? Sore throat is one symptom of an array of different medical disorders. Infections cause the majority of sore throats, and these are the sore throats that are contagious (can be passed from one person to another). Infections are caused by either viruses (such as the "flu," the "common cold" or mononucleosis) or bacteria (such as "strep," mycoplasma or hemophilus). The most important difference between viruses and bacteria is that bacteria respond well to antibiotic treatment, but viruses do not. Viruses Most viral sore throats accompany the "flu" or a "cold." when a stuff-runny nose, sneezing, and generalized aches and pains accompany the sore throat, it is probably caused by one of the hundreds of known viruses. These are highly contagious and cause epidemics in a community, especially in the winter. The body cures itself of a viral infection by building antibodies that destroy the virus, a process that takes about a week. Sore throats accompany other viral infections such as measles, chicken pox, whooping cough, and croup. Canker sores and fever blisters in the throat also can be very painful. One special viral infection takes much longer than a week to be cured: infectious mononucleosis or "mono." This virus lodges in the lymph system, causing massive enlargement of the tonsils (with white patches on their surface) and swollen glands in the neck, armpits and groin. it creates a severely sore throat, sometimes causes serious difficulties breathing, and can affect the liver, leading to jaundice (yellow skin and eyes). -
An Approach to Interpreting Restrictive Spirometric Pattern Results In
Med Lav 2016; 107, 6: 419-436 An approach to interpreting restrictive spirometric pattern results in occupational settings Federica Tafuro, Massimo Corradi Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy KEY WORDS Diagnostic algorithm; FEV1; FVC; FEV6; FEV1/FVC; interpretative criteria; lung function testing; occupa- tional exposure PAROLE CHIAVE Algoritmi diagnostici; FEV1; FVC; FEV6; FEV1/FVC; criteri interpretativi; test di funzionalità polmonare; esposizione occupazionale SUMMARY Objectives: The aim of this review is to provide an updated overview of definition, epidemiology, diagnostic algo- rithm and occupational exposures related to abnormal restrictive spirometrical pattern (RSP) in order to improve the correct interpretation of spirometry test results by occupational healthcare providers. Methods: A review of the scien- tific English literature of the last 25 years was carried out with MEDLINE and related keywords [(restricti* AND spirometr*) AND occupational]. The first step analysis covered 40 studies and the second step the reference list. Results are presented in four major aims and subquestions. Results: A spirometrical pattern of reduced VC (Vital Capacity), together with a normal FEV1 (Forced Expiratory Volume in 1 Second)/VC ratio, is suggestive, though not diagnostic of restrictive ventilatory defect (RVD). The prevalence of RSP is high in some studies, comparable to obstructive pat- tern, and could be associated to chronic medical conditions (diabetes, congestive heart failure, obesity, hypertension) as well as to increased risk of mortality and lung cancer. In order to predict true restrictive defect [TLC-(Total Lung Capacity) <LLN (Lower Limit of Normality) gold-standard for diagnosing restrictive lung diseases (RLD)] from spirometrical data, mathematical models have been developed, but more studies in occupational setting are necessary to clarify the accuracy of such approaches in health surveillance programmes. -
Evaluation of Metal and Noise Exposures at an Aircraft Powerplant Parts Manufacturer
Evaluation of Metal and Noise Exposures at an Aircraft Powerplant Parts Manufacturer HHE Report No. 2018-0001-3349 April 2019 Authors: Karl D. Feldmann, MS, CIH David A. Jackson, MD Analytical Support: Jennifer Roberts, Maxxam Analytics Desktop Publisher: Jennifer Tyrawski Editor: Cheryl Hamilton Industrial Hygiene Field Assistance: Scott Brueck, Jessica Li, Kevin Moore Logistics: Donnie Booher, Kevin Moore, Mihir Patel Medical Field Assistance: Deborah Sammons, Miriam Siegel Statistical Support: Miriam Siegel Keywords: North American Industry Classification System (NAICS) Code 336412 (Aircraft Engine and Engine Parts Manufacturing), Oregon, Welding, Tungsten Inert Gas, TIG Welding, Inconel, Stainless Steel, Chromium, Hexavalent Chromium, Hex Chrome, Chrome Six, Chrome 6, Chrome IV, Crvi, Cr(VI), Nickel, Cobalt, Biomonitoring, BEI, Noise Disclaimer The Health Hazard Evaluation Program investigates possible health hazards in the workplace under the authority of the Occupational Safety and Health Act of 1970 [29 USC 669a(6)]. The Health Hazard Evaluation Program also provides, upon request, technical assistance to federal, state, and local agencies to investigate occupational health hazards and to prevent occupational disease or injury. Regulations guiding the Program can be found in Title 42, Code of Federal Regulations, Part 85; Requests for Health Hazard Evaluations [42 CFR Part 85]. Availability of Report Copies of this report have been sent to the employer and employee representative at the facility. The state and local health department and the Occupational Safety and Health Administration Regional Office have also received a copy. This report is not copyrighted and may be freely reproduced. Recommended Citation NIOSH [2019]. Evaluation of metal and noise exposures at an aircraft powerplant parts manufacturer. -
COVID-19 Pneumonia: the Great Radiological Mimicker
Duzgun et al. Insights Imaging (2020) 11:118 https://doi.org/10.1186/s13244-020-00933-z Insights into Imaging EDUCATIONAL REVIEW Open Access COVID-19 pneumonia: the great radiological mimicker Selin Ardali Duzgun* , Gamze Durhan, Figen Basaran Demirkazik, Meltem Gulsun Akpinar and Orhan Macit Ariyurek Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread worldwide since December 2019. Although the reference diagnostic test is a real-time reverse transcription-polymerase chain reaction (RT-PCR), chest-computed tomography (CT) has been frequently used in diagnosis because of the low sensitivity rates of RT-PCR. CT fndings of COVID-19 are well described in the literature and include predominantly peripheral, bilateral ground-glass opacities (GGOs), combination of GGOs with consolida- tions, and/or septal thickening creating a “crazy-paving” pattern. Longitudinal changes of typical CT fndings and less reported fndings (air bronchograms, CT halo sign, and reverse halo sign) may mimic a wide range of lung patholo- gies radiologically. Moreover, accompanying and underlying lung abnormalities may interfere with the CT fndings of COVID-19 pneumonia. The diseases that COVID-19 pneumonia may mimic can be broadly classifed as infectious or non-infectious diseases (pulmonary edema, hemorrhage, neoplasms, organizing pneumonia, pulmonary alveolar proteinosis, sarcoidosis, pulmonary infarction, interstitial lung diseases, and aspiration pneumonia). We summarize the imaging fndings of COVID-19 and the aforementioned lung pathologies that COVID-19 pneumonia may mimic. We also discuss the features that may aid in the diferential diagnosis, as the disease continues to spread and will be one of our main diferential diagnoses some time more. -
SINUSITIS AS a CAUSE of TONSILLITIS. by BEDFORD RUSSELL, F.R.C.S., Surgeon-In-Charge, Throat Departmentt, St
Postgrad Med J: first published as 10.1136/pgmj.9.89.80 on 1 March 1933. Downloaded from 80 POST-GRADUATE MEDICAL JOURNAL March, 1933 Plastic Surgery: A short course of lecture-demonstrations is being arranged, to be given at the Hammersmith Hospitar, by Sir Harold Gillies, Mr. MacIndoe and Mr. Kilner. Details will be circulated shortly. Technique of Operations: A series of demonstrations is being arranged. Details will be circulated shortly. Demonstrations in (Advanced) Medicine and Surgeryi A series of weekly demonstrations is being arranged. Details will be circulated shortly. A Guide Book, giving details of how to reach the various London Hospitals by tube, tram, or bus, can be obtained from the Fellowship. Price 6d. (Members and Associates, 3d.). SINUSITIS AS A CAUSE OF TONSILLITIS. BY BEDFORD RUSSELL, F.R.C.S., Surgeon-in-Charge, Throat Departmentt, St. Bart's Hospital. ALTHOUGH the existence of sinus-infection has long since been recognized, medical men whose work lies chiefly in the treatment of disease in the nose, throat and ear are frequently struck with the number of cases of sinusitis which have escaped recognition,copyright. even in the presence of symptoms and signs which should have given rise at least to suspicion of such disease. The explanation of the failure to recognize any but the most mlianifest cases of sinusitis lies, 1 think, in the extreme youth of this branch of medicine; for although operations upon the nose were undoubtedly performed thousands of years ago, it was not uintil the adoption of cocaine about forty years ago that it was even to examine the nasal cavities really critically. -
ICD-10 Coordination and Maintenance Committee Meeting Diagnosis Agenda March 5-6, 2019 Part 2
ICD-10 Coordination and Maintenance Committee Meeting Diagnosis Agenda March 5-6, 2019 Part 2 Welcome and announcements Donna Pickett, MPH, RHIA Co-Chair, ICD-10 Coordination and Maintenance Committee Diagnosis Topics: Contents Babesiosis ........................................................................................................................................... 10 David, Berglund, MD Mikhail Menis, PharmD, MS Epi, MS PHSR Epidemiologist Office of Biostatistics and Epidemiology CBER/FDA C3 Glomerulopathy .......................................................................................................................... 13 David Berglund, MD Richard J. Hamburger, M.D. Professor Emeritus of Medicine, Indiana University Renal Physicians Association Eosinophilic Gastrointestinal Diseases ............................................................................................ 18 David Berglund, MD Bruce Bochner, MD Samuel M. Feinberg Professor of Medicine Northwestern University Feinberg School of Medicine and President, International Eosinophil Society ICD-10 Coordination and Maintenance Committee Meeting March 5-6, 2019 Food Insecurity.................................................................................................................................. 20 Donna Pickett Glut1 Deficiency ................................................................................................................................ 23 David Berglund, MD Hepatic Fibrosis ............................................................................................................................... -
Diagnosis and Treatment of Acute Pharyngitis/Tonsillitis: a Preliminary Observational Study in General Medicine
Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2016; 20: 4950-4954 Diagnosis and treatment of acute pharyngitis/tonsillitis: a preliminary observational study in General Medicine F. DI MUZIO, M. BARUCCO, F. GUERRIERO Azienda Sanitaria Locale Roma 4, Rome, Italy Abstract. – OBJECTIVE : According to re - pharmaceutical expenditure, without neglecting cent observations, the insufficiently targeted the more important and correct application of use of antibiotics is creating increasingly resis - the Guidelines with performing of a clinically val - tant bacterial strains. In this context, it seems idated test that carries advantages for reducing increasingly clear the need to resort to extreme the use of unnecessary and potentially harmful and prudent rationalization of antibiotic thera - antibiotics and the consequent lower prevalence py, especially by the physicians working in pri - and incidence of antibiotic-resistant bacterial mary care units. In clinical practice, actually the strains. general practitioner often treats multiple dis - eases without having the proper equipment. In Key Words: particular, the use of a dedicated, easy to use Acute pharyngitis, Tonsillitis, Strep throat, Beta-he - diagnostic test would be one more weapon for molytic streptococcus Group A (GABHS), Rapid anti - the correct diagnosis and treatment of acute gen detection test, Appropriateness use of antibiotics, pharyngo-tonsillitis. The disease is a condition Cost savings in pharmaceutical spending. frequently encountered in clinical practice but -
Am I Missing Something? Blindness • Dan Simons and Chris Chabris: Video Studies Created During Experimental Psychology Course
5/24/2018 Is This Normal Lung? Looking Beyond the Interstitium Kirk D. Jones, MD UCSF Dept of Pathology [email protected] Inattentional Blindness • Ulric Neisser: Selective looking • Arien Mack and Irvin Rock: Inattentional Am I Missing Something? blindness • Dan Simons and Chris Chabris: Video studies created during Experimental Psychology course 1 5/24/2018 Inattentional Blindness • “when our attention is focused on one thing, we fail to notice other, unexpected things around us—including those we might want to see.” • In pathology of the lung, there are often two things that focus our attention: – The tumor in neoplastic disease – The alveoli in non-neoplastic disease The Neglected Compartments • Bronchioles – Inflammatory bronchiolitis – Fibrotic bronchiolitis ALVEOLI • Vessels – Pulmonary arteriopathy – Pulmonary venopathy • Pleura – Pleural inflammation or neoplasm bronchioles vessels pleura • Absence of alveoli – Cystic disease 2 5/24/2018 Overview of Talk • Bronchioles – Bronchiolitis – Diffuse panbronchiolitis – Constrictive bronchiolitis • Vessels – Pulmonary arteriopathy – Pulmonary veno-occlusive disease • Lack of alveoli – cystic disease – Lymphangioleiomyomatosis Classification of Bronchiolitis • Cellular infiltrates (inflammatory) – Intraluminal • Neutrophils: Acute bronchiolitis, bronchopneumonia • Macrophages: Respiratory bronchiolitis – Mural • Lymphocytes: Chronic/cellular bronchiolitis • Lymphoid follicles: Follicular bronchiolitis – Peribronchiolar/Interstitial • Macrophages: Diffuse panbronchiolitis 3 5/24/2018 -
9.1 Appendix a Minimum Respiratory Protection for Cutting and Welding Processes
Safety Policy and Procedure Policy Number 015 Authorized By: The Cianbro Companies Alan Burton Title: Welding and Cutting Hazard Assessment Program Effective Date: 09/16/95 Page 1 of 12 1 Status 1.1 Update of existing policy, effective 06/03/11. 2 Purpose 2.1 To provide guidelines and requirements to protect team members from the hazards associated with welding, cutting, and burning operations. 3 Applicability 3.1 This policy applies to all subsidiary companies and departments of the Cianbro Companies. 3.2 All organizations are required to comply with the provisions of this policy and procedure. Any deviation, unless spelled out specifically in the policy, requires the permission of the Safety Director or designee. 4 Definitions 4.1 Adequate Ventilation: Used in this policy means any of the following: Local exhaust ventilation is used to capture fumes or in open area with adequate air movement or adequate dilution ventilation with directional air flow away from team member. 4.2 Air Arc (Carbon Arc): A cutting process by which metals are melted by the heat of an arc using a carbon electrode. Molten metal is forced away from the cut by a blast of forced air. 4.3 Bug-O BUG-O Systems Inc.: A manufacturer of a system of drives, carriages, rails and attachments designed to automate welding guns, cutting torches and other hand held tools. 4.4 Cad Welding: An exothermic (gives off heat) welding process that fuses conductors together to form a molecular bond with a current-carrying capacity equal to that of the conductor. Typically used in grounding systems.